Changes in a8dd2c8: update

				PMBL_genes.md
			
          @@ -11,7 +11,7 @@ link-citations: true

           ## Tier 1, high-confidence PMBL genes

          -### *76 total*

          +### *74 total*

           |Gene|Summary| First PMBL study | Other entities | QC result |

           |:-:|:--:|:-:|:-|:-|

          @@ -23,8 +23,6 @@ link-citations: true

           |[BTG1](BTG1)|Tier 1 GE[@sarkozyMutationalLandscapeGray2021], FE[@almasmoumFrequentLossBTG12021], aSHM|[Sarkozy et al](papers/sarkozyMutationalLandscapeGray2021)|[@burkhardtClinicalRelevanceMolecular2022; @drevalGeneticSubdivisionsFollicular2023; @morinFrequentMutationHistonemodifying2011]||

           |[CD58](CD58)|Tier 1 GE[@schneiderAlterationsCD58Gene2015], FE[@challa-malladiCombinedGeneticInactivation2011]|[Schneider et al](papers/schneiderAlterationsCD58Gene2015)|[@morinFrequentMutationHistonemodifying2011]||

           |[CD83](CD83)|Tier 1 GE[@dunsCharacterizationDLBCLPMBL2021], aSHM|[Duns et al](papers/dunsCharacterizationDLBCLPMBL2021)|[@morinMutationalStructuralAnalysis2013; @paneaWholeGenomeLandscape2019; @russler-germainMutationsAssociatedProgression2023]||

          -|[CDKN2A](CDKN2A)|Tier 1 GE[@], FE[@kannengiesserFunctionalStructuralGenetic2009]||[@grandeGenomewideDiscoverySomatic2019; @morinMutationalStructuralAnalysis2013; @spinaGeneticsNodalMarginal2016]||

          -|[CHD8](CHD8)|Tier 1 GE[@]||[@grandeGenomewideDiscoverySomatic2019]||

           |[CIITA](CIITA)|Tier 1 GE[@mottokGenomicAlterationsCIITA2015], FE[@mottokGenomicAlterationsCIITA2015], aSHM|[Mottok et al](papers/mottokGenomicAlterationsCIITA2015)|[@morinFrequentMutationHistonemodifying2011]||

           |[CISH](CISH)|Tier 1 GE[@mottokIntegrativeGenomicAnalysis2019]|[Mottok et al](papers/mottokIntegrativeGenomicAnalysis2019)|||

           |[CREBBP](CREBBP)|Tier 1 GE[@dunsCharacterizationDLBCLPMBL2021], FE[@pasqualucciInactivatingMutationsAcetyltransferase2011]|[Duns et al](papers/dunsCharacterizationDLBCLPMBL2021)|[@loveGeneticLandscapeMutations2012; @parryWholeExomeSequencing2013; @pasqualucciInactivatingMutationsAcetyltransferase2011]||

          @@ -94,7 +92,7 @@ link-citations: true

           ## Tier 2, low-confidence PMBL genes

          -### *82 total*

          +### *84 total*

           |Gene|Summary| First PMBL study | Other entities | QC result |

           |:-:|:--:|:-:|:-|:-|

          @@ -109,6 +107,8 @@ link-citations: true

           |[CCND3](CCND3)|Tier 2 GE[@deschGenotypingCirculatingTumor2020], FE[@schmitzBurkittLymphomaPathogenesis2012]|[Desch et al](papers/deschGenotypingCirculatingTumor2020)|[@jalladesExomeSequencingIdentifies2017; @morinFrequentMutationHistonemodifying2011; @richterRecurrentMutationID32012]||

           |[CDH2](CDH2)|Tier 2 GE[@deschGenotypingCirculatingTumor2020]|[Desch et al](papers/deschGenotypingCirculatingTumor2020)|||

           |[CDH5](CDH5)|Tier 2 GE[@gomezUltraDeepSequencingReveals2023]|[Gomez et al](papers/gomezUltraDeepSequencingReveals2023)|||

          +|[CDKN2A](CDKN2A)|Tier 2 GE, FE[@kannengiesserFunctionalStructuralGenetic2009]||[@grandeGenomewideDiscoverySomatic2019; @morinMutationalStructuralAnalysis2013; @spinaGeneticsNodalMarginal2016]||

          +|[CHD8](CHD8)|Tier 2 GE||[@grandeGenomewideDiscoverySomatic2019]||

           |[CXCR5](CXCR5)|Tier 2 GE[@mottokIntegrativeGenomicAnalysis2019]|[Mottok et al](papers/mottokIntegrativeGenomicAnalysis2019)|[@schmitzGeneticsPathogenesisDiffuse2018]||

           |[DGKB](DGKB)|Tier 2 GE[@tiacciPervasiveMutationsJAKSTAT2018]|[Tiacci et al](papers/tiacciPervasiveMutationsJAKSTAT2018)|||

           |[DMD](DMD)|Tier 2 GE[@reichelFlowSortingExome2015]|[Reichel et al](papers/reichelFlowSortingExome2015)|||

...	...	@@ -11,7 +11,7 @@ link-citations: true
11	11
12	12	## Tier 1, high-confidence PMBL genes
13	13
14		-### 76 total
	14	+### 74 total
15	15
16	16	\|Gene\|Summary\| First PMBL study \| Other entities \| QC result \|
17	17	\|:-:\|:--:\|:-:\|:-\|:-\|
...	...	@@ -23,8 +23,6 @@ link-citations: true
23	23	\|[BTG1](BTG1)\|Tier 1 GE[@sarkozyMutationalLandscapeGray2021], FE[@almasmoumFrequentLossBTG12021], aSHM\|[Sarkozy et al](papers/sarkozyMutationalLandscapeGray2021)\|[@burkhardtClinicalRelevanceMolecular2022; @drevalGeneticSubdivisionsFollicular2023; @morinFrequentMutationHistonemodifying2011]\|\|
24	24	\|[CD58](CD58)\|Tier 1 GE[@schneiderAlterationsCD58Gene2015], FE[@challa-malladiCombinedGeneticInactivation2011]\|[Schneider et al](papers/schneiderAlterationsCD58Gene2015)\|[@morinFrequentMutationHistonemodifying2011]\|\|
25	25	\|[CD83](CD83)\|Tier 1 GE[@dunsCharacterizationDLBCLPMBL2021], aSHM\|[Duns et al](papers/dunsCharacterizationDLBCLPMBL2021)\|[@morinMutationalStructuralAnalysis2013; @paneaWholeGenomeLandscape2019; @russler-germainMutationsAssociatedProgression2023]\|\|
26		-\|[CDKN2A](CDKN2A)\|Tier 1 GE[@], FE[@kannengiesserFunctionalStructuralGenetic2009]\|\|[@grandeGenomewideDiscoverySomatic2019; @morinMutationalStructuralAnalysis2013; @spinaGeneticsNodalMarginal2016]\|\|
27		-\|[CHD8](CHD8)\|Tier 1 GE[@]\|\|[@grandeGenomewideDiscoverySomatic2019]\|\|
28	26	\|[CIITA](CIITA)\|Tier 1 GE[@mottokGenomicAlterationsCIITA2015], FE[@mottokGenomicAlterationsCIITA2015], aSHM\|[Mottok et al](papers/mottokGenomicAlterationsCIITA2015)\|[@morinFrequentMutationHistonemodifying2011]\|\|
29	27	\|[CISH](CISH)\|Tier 1 GE[@mottokIntegrativeGenomicAnalysis2019]\|[Mottok et al](papers/mottokIntegrativeGenomicAnalysis2019)\|\|\|
30	28	\|[CREBBP](CREBBP)\|Tier 1 GE[@dunsCharacterizationDLBCLPMBL2021], FE[@pasqualucciInactivatingMutationsAcetyltransferase2011]\|[Duns et al](papers/dunsCharacterizationDLBCLPMBL2021)\|[@loveGeneticLandscapeMutations2012; @parryWholeExomeSequencing2013; @pasqualucciInactivatingMutationsAcetyltransferase2011]\|\|
...	...	@@ -94,7 +92,7 @@ link-citations: true
94	92
95	93	## Tier 2, low-confidence PMBL genes
96	94
97		-### 82 total
	95	+### 84 total
98	96
99	97	\|Gene\|Summary\| First PMBL study \| Other entities \| QC result \|
100	98	\|:-:\|:--:\|:-:\|:-\|:-\|
...	...	@@ -109,6 +107,8 @@ link-citations: true
109	107	\|[CCND3](CCND3)\|Tier 2 GE[@deschGenotypingCirculatingTumor2020], FE[@schmitzBurkittLymphomaPathogenesis2012]\|[Desch et al](papers/deschGenotypingCirculatingTumor2020)\|[@jalladesExomeSequencingIdentifies2017; @morinFrequentMutationHistonemodifying2011; @richterRecurrentMutationID32012]\|\|
110	108	\|[CDH2](CDH2)\|Tier 2 GE[@deschGenotypingCirculatingTumor2020]\|[Desch et al](papers/deschGenotypingCirculatingTumor2020)\|\|\|
111	109	\|[CDH5](CDH5)\|Tier 2 GE[@gomezUltraDeepSequencingReveals2023]\|[Gomez et al](papers/gomezUltraDeepSequencingReveals2023)\|\|\|
	110	+\|[CDKN2A](CDKN2A)\|Tier 2 GE, FE[@kannengiesserFunctionalStructuralGenetic2009]\|\|[@grandeGenomewideDiscoverySomatic2019; @morinMutationalStructuralAnalysis2013; @spinaGeneticsNodalMarginal2016]\|\|
	111	+\|[CHD8](CHD8)\|Tier 2 GE\|\|[@grandeGenomewideDiscoverySomatic2019]\|\|
112	112	\|[CXCR5](CXCR5)\|Tier 2 GE[@mottokIntegrativeGenomicAnalysis2019]\|[Mottok et al](papers/mottokIntegrativeGenomicAnalysis2019)\|[@schmitzGeneticsPathogenesisDiffuse2018]\|\|
113	113	\|[DGKB](DGKB)\|Tier 2 GE[@tiacciPervasiveMutationsJAKSTAT2018]\|[Tiacci et al](papers/tiacciPervasiveMutationsJAKSTAT2018)\|\|\|
114	114	\|[DMD](DMD)\|Tier 2 GE[@reichelFlowSortingExome2015]\|[Reichel et al](papers/reichelFlowSortingExome2015)\|\|\|